United States · 
What does SCP Vitalife Partners invest in?
SCP Vitalife Partners invests most often at Series C and Series D (50% of the rounds on record), in sectors such as Biotechnology and Therapeutics.
SCP Vitalife Partners highlights
- 01
8 rounds on record
- 02
Mostly Series C and Series D: 50% of its rounds
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- BiotechnologyTherapeutics
- Based in
- Wayne, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first8 appearances
- 2015
1 round
- Sept
- 2013
2 rounds
- Jun
- Mar
- 2012
1 round
- Feb
- 2011
2 rounds
- Aug
- Jul
- 2009
2 rounds
- Aug
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
ALAbraham LudomirskiManaging MemberiForm ADV
JDJeffrey DykanManaging MemberiForm ADV
WBWayne B WeismanManaging MemberiForm ADV
WCWinston ChurchillManaging MemberiForm ADV
We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$105Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- SCP Vitalife Management Company, LLC
- SEC number
- CRD 161969